With more than 200 public biotechnology companies from which to choose, many investors
have difficulty telling one outfit from the next. Faced with a bewildering array of products and …

The ongoing biotechnology revolution provides an ideal context for research in strategic
choices because of the major technological changes in progress, the wide range of …

Recently, biotech companies are increasingly attracting the attention from investors. From
2016, of the top 10 performers in the NASDAQ-100 (index consisting of 100 largest non …

Economics, and Thomas Brenner, of Philipps University Marburg, represents volume 4 in the
International Handbook Series on Entrepreneurship. This book is a collection of articles …

The motivation (and personal ex-ante assumption) for this chapter comes from our combined
20 years' experience of research, consulting, operational positions, and ownership of more …

Drug development biotechnology firms are most appropriately conceptualized as
intermediaries in the pharmaceutical R&D value chain. Because they generally do not …

All biotechnology products originate from underlying technology research and product
concepts that are based upon novel science. In reality, there is no shortage of product ideas …

This second edition of Biotechnology Entrepreneurship: Leading, Managing, and
Commercializing Innovative Technologies is an authoritative, easy-to-read guide covering …

One comment often repeated to me by coworkers in the biotechnology industry deals with
their frustration at not understanding how their particular roles fit into their company's overall …

Biotechnology companies will find themselves confronted with a set of challenges in the next
years. Internationalization, cooperative activities, and mergers and acquisitions are the most …